HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kayo Ikeda Selected Research

Cefozopran

4/2008Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
4/2008Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
12/2007Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection.
10/2007Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kayo Ikeda Research Topics

Disease

8Intraabdominal Infections
11/2008 - 10/2007
3Critical Illness (Critically Ill)
12/2009 - 02/2008
2Neoplasms (Cancer)
05/2020 - 10/2009
2Inflammation (Inflammations)
11/2017 - 02/2015
2Prostatitis
03/2013 - 02/2012
2Infections
12/2011 - 04/2008
2Body Weight (Weight, Body)
02/2010 - 04/2008
2Febrile Neutropenia
04/2008 - 12/2007
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
05/2020
1Neoplasm Metastasis (Metastasis)
05/2020
1Leiomyoma (Uterine Fibroids)
05/2020
1Biliary Atresia
03/2019
1Obesity
01/2016
1Pancreatitis
05/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2013
1Fibrosis (Cirrhosis)
12/2012
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2012
1Aspergillosis
10/2009
1Candidiasis (Moniliasis)
10/2009
1Acute Kidney Injury (Acute Renal Failure)
10/2008
1Sepsis (Septicemia)
10/2008
1Bacterial Meningitis
07/2008
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2008
1Hypersensitivity (Allergy)
09/2006

Drug/Important Bio-Agent (IBA)

4Meropenem (Merrem)FDA LinkGeneric
05/2013 - 07/2008
4biapenem (L 627)IBA
12/2011 - 02/2008
4CefozopranIBA
04/2008 - 10/2007
3Pharmaceutical PreparationsIBA
01/2016 - 10/2009
3DoripenemFDA Link
02/2012 - 12/2007
3Carbapenems (Carbapenem Antibiotics)IBA
12/2011 - 12/2007
2CreatinineIBA
02/2010 - 04/2008
1lipoarabinomannan (LAM)IBA
05/2020
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2019
1Isoleucine (L-Isoleucine)FDA Link
11/2017
1Adenosine Triphosphate (ATP)IBA
02/2015
1Immunoglobulins (Immunoglobulin)IBA
02/2015
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2015
1nucleotide pyrophosphataseIBA
02/2015
1Interleukin-17 (Interleukin 17)IBA
01/2013
1arbekacinIBA
12/2009
1Dialysis SolutionsIBA
12/2009
1Polymethyl Methacrylate (Sol)IBA
12/2009
1Micafungin (FK463)FDA Link
10/2009
1Anti-Bacterial Agents (Antibiotics)IBA
04/2008
1Cefepime (Maxipime)FDA LinkGeneric
04/2008
1ImipenemFDA Link
01/2008
1Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA
09/2006

Therapy/Procedure

3Continuous Renal Replacement Therapy
12/2009 - 02/2008
1Hysterectomy
05/2020
1Liver Transplantation
12/2012
1Critical Care (Surgical Intensive Care)
10/2008
1Gynecologic Surgical Procedures (Gynecologic Surgery)
04/2008
1Laparotomy
04/2008